Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC
Clinical trial NCT03136627 · COMPLETED
Trial details
- NCT number
- NCT03136627
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-22
- Primary completion
- 2017-12-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.